Talking about what others are afraid to say
A month and a half after Revolution Medicines launched its pancreatic cancer pill, I keep running into the same two thoughts. The drug is a real breakthrough. And some of …
Rasonque Is About to Face Competition. Did They Overestimate Their Sales Forecast? Read More
Yet again, a study finds that doctors who are paid or given gifts by pharma companies are more likely to prescribe more drugs from those companies. Of course they do. …
Are Doctors Prescribing More Due to Pharma Influence? Read More
The pharma industry’s latest lawsuit against Medicare’s most-favored-nation pricing experiment reveals just how far drugmakers will go to protect their pricing power, illustrating a fierce commitment to maintaining profit margins …
PhRMA Is Suing to Keep Drug Prices High. Once Again, Patients Are Paying the Price Read More
RASONQUE may be one of the most important oncology launches in years, but its long-term commercial story is far from settled. Daraxonrasib has delivered a remarkable survival benefit in metastatic …
Did Revolution Count Their Potential Earnings Too Quickly? Read More
Spend a night in a hospital and you quickly discover something strange about American healthcare: we talk endlessly about being patient-centered, yet the actual experience of being a patient can …
Hospitals Need to Remember What It’s Like to Be a Patient Read More
For those of us who work in the pharma industry, we bear a great responsibility. Sure, we have responsibilities to our employers. We have budgets to meet, forecasts to achieve, …
Bringing the Patient Perspective into Pharma Decisions Read More
A huge new pancreatic cancer drug just got FDA approval. The data are amazing. But the price tag will leave many people in deep medical debt, if they can afford …
The Real Economics of the New Pancreatic Cancer Drug: When Six More Months Could Cost Hundreds of Thousands Read More
Prior authorization has become one of healthcare’s favorite villains. Physicians loathe it. Patients despise it. Drug companies decry it. Hospitals rail against it. And insurers have given everyone plenty of …
PR Releases On Prior Authorizations Don’t Tell A Story Read More